| June 1 |
Bristol-Myers Squibb Awards Immunicon New Research Services
Agreement for Oncology Biomarker Development |
| June 1 |
Mylan Wins Omeprazole Patent Litigation |
| June 1 |
Jazz Pharmaceuticals, Inc. Announces Initial Public Offering |
| June 1 |
Nventa Consolidates Offices Into San Diego |
| June 1 |
Black Horse Capital Opposes the Strategic Direction of Cypress
Bioscience |
| June 1 |
MOLOGEN AG Sells Spanish Subsidiary |
| June 1 |
Isogenica Enters into Research and License Agreement with Wyeth |
| June 1 |
Revision - Decision Fails Patients with Transfusion-Dependent
Anemia |
| June 1 |
Termination of Development of Fixed Dose Combination Product of
Actos + TAK-536 |
| June 1 |
AstraZeneca’s Prilosec Patents Upheld By Court |
| June 1 |
Barr Confirms Decision in Azithromycin Inventorship Suit |
| June 1 |
Pharmaceutical Blog Chatter Continues About Dr. Steven
Nissen’s Avandia Revelations, Most Bloggers Refute |
| June 1 |
Transition Therapeutics Acquires All Remaining Shares of NeuroMedix
Inc. |
| June 1 |
ImpaxX Announces Decision on Generic Prilosec Litigation |
| June 4 |
Bayer Schering Pharma AG Will Terminate Registration With the U.S.
SEC |
| June 4 |
Final Data from a Phase 2 Trial Presented at ASCO Specifies
Dose-dependent Activity of Adecatumumab (MT201) |
| June 4 |
AstraZeneca Acquires Biologics Manufacturing Facility in Canada |
| June 4 |
Cell Genesys and Medarex Report Follow-Up Data From a Phase 1
Combination Therapy Trial With GVAX Immunotherapy for Prostate
Cancer and Ipilimumab (MDX-010) Antibody |
| June 4 |
New Data Evaluating Sutent, CP-751,871 and Axitinib in Patients
with Non-Small Cell Lung Cancer |
| June 4 |
Phase III Study Shows Avastin Plus Interferon Therapy Nearly
Doubled Median Progression-Free Survival in Patients With
Previously Untreated Advanced Kidney Cancer |
| June 4 |
GlaxoSmithKline Reports Positive New Data on Tykerb at the 2007
ASCO Annual Meeting |
| June 4 |
Phase III Ixabepilone Study Demonstrated Significant Improvement in
Progression-Free Survival in Patients With Advanced Metastatic
Breast Cancer |
| June 4 |
Telik Announces Top-Line Results of TELCYTA ASSIST-2 Trial |
| June 4 |
Telik Reports Results of TELCYTA ASSIST-1 Trial |
| June 4 |
Telik Reports Results of TELCYTA Assist-3 Trial |
| June 4 |
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac
Weekly |
| June 4 |
DTC Advertising Improvements Observed In Two New Reports |
| June 4 |
FDA Announces New Advisory Committee to Address Risk Communication |
| June 5 |
Neurogen Announces Continuing Preclinical and Clinical Development
Work and Conclusion of Research Component of Collaboration for
Investigational Pain Drug |
| June 5 |
APT Acquires Exclusive Worldwide Rights to Develop and
Commercialize Inhalable Cyclosporine to Prevent Lung Transplant
Rejection |
| June 5 |
Eurand and GSK Reach Development Milestone |
| June 5 |
Telik Announces Clinical Hold on TELCYTA Trials |
| June 5 |
Amgen to Acquire Ilypsa, a Private San Francisco Bay Area
Biotechnology Company Focused on Kidney Disease Care |
| June 5 |
Corautus Genetics Stockholders Approve Merger with VIA
Pharmaceuticals and Related Proposals |
| June 5 |
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for
Head & Neck Cancer |
| June 5 |
Valeant Pharmaceuticals Agrees to Sell Manufacturing Facilities in
Basel, Switzerland and Humacao, Puerto Rico |
| June 5 |
Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life
Sciences, Inc. |
| June 5 |
Mylan Wins Its Amlodipine Case With Pfizer |
| June 6 |
CRO Company Merger; A First for China's Drug Development Contract
Research Organization Industry |
| June 6 |
GlaxoSmithKline Response to New England Journal of Medicine
Editorials |
| June 6 |
VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form
VIA Pharmaceuticals, Inc. |
| June 6 |
AstraZeneca CFO to Join Goldman Sachs |
| June 6 |
WaferGen Completes Merger and Private Placement of $10.7 Million |
| June 6 |
Abbott and Caprion Extend Partnership to Discover Antibody Targets
for Cancer |
| June 6 |
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology
Company in Cambridge, Massachusetts |
| June 6 |
Statement of Moncef Slaoui, PhD, Chairman Research &
Development GlaxoSmithKline |
| June 7 |
American Diabetes Association Strongly Advises Patients Using
Rosiglitazone to See Their Doctor |
| June 7 |
Takeda Revises Actos (pioglitazone HCl) Prescribing Label |
| June 7 |
Roche Recalls Viracept Due to Chemical Impurity |
| June 7 |
Agilent Technologies Adds Strength to Its Life Science Business
With Acquisition of Stratagene |
| June 7 |
Intertek Acquires QTI Laboratory |
| June 7 |
Forbion Announces Successful Exit from Alantos Pharmaceuticals |
| June 7 |
Genzyme to Build New Biomanufacturing Plant to Support Growth of
Thymoglobulin |
| June 7 |
Eli Lilly and Company Comments on Recent Court Rulings Regarding
Zyprexa Patents |
| June 8 |
Radiant Research Acquired by New Ownership Group |
| June 8 |
Schering-Plough and Bayer Healthcare Announce Availability of ZETIA
in Japan, the First Cholesterol-Lowering Agent With a Novel
Mechanism of Action Approved in Japan in 18 Years |
| June 8 |
Johnson & Johnson Highlights Growth Strategies for
Pharmaceutical and Consumer Businesses |
| June 8 |
On the Launch and Measures for Proper Use of the Anti-Cancer Agent
Avastin |
| June 8 |
Renovis Announces Achievement of Milestones in VR1 Collaboration
with Pfizer Inc. |
| June 8 |
Pharma Blogs This Week: Hot & Heavy Congressional Committee
Hearings, DTC Study Shows No Effect on Pricing, and Another Pharma
CFO Bites the Dust |
| June 8 |
FDA Science Board to Meet on June 14 |
| June 11 |
ZARS, Inc. Files Registration Statement for Initial Public Offering |
| June 11 |
Announcement of the Launch of the Selective COX-2 Inhibitor Celecox
Tablets in Japan |
| June 11 |
Kurve Technology and Schering-Plough Sign Expanded Technology
Agreement |
| June 11 |
Archemix and Merck KGaA Sign Strategic Alliance |
| June 11 |
AMRI Receives Milestone Payment From Licensing Agreement with
Bristol-Myers Squibb |
| June 11 |
Archemix and Takeda to Enter into Collaboration for Discovery and
Development of Aptamer Therapeutics |
| June 11 |
Merck Signs Strategic Alliance With Archemix |
| June 11 |
Pediatric Inhaled Corticosteroid Asthma Medication Features New
Dose Counters to Help Track Usage |
| June 11 |
Barr Announces Withdrawal of Zyprexa Zydis Patent Litigation |
| June 11 |
Teva Receives Favorable Court Decision Regarding Generic Lotrel;
Novartis' Motion for Preliminary Injunction Denied |
| June 11 |
US Court Allows Teva to Resume US Sales of Its Generic Version of
Lotrel |
| June 11 |
Athersys Raises $65 Million in Concurrent Reverse Merger and
Private Equity Offering |
| June 11 |
U.S. Department of Justice Investigation of Bristol-Myers Squibb in
Proposed Plavix Patent Settlement Is Resolved |
| June 12 |
alli - The OTC Weight Loss Product - On Shelves Nationwide Later
This Week |
| June 12 |
Vical Receives $6 Million Grant From NIH to Advance RapidResponse
DNA Vaccine Platform |
| June 12 |
BioSante Pharmaceuticals Announces Reinitiation of Product
Development With Teva |
| June 12 |
Kissei and Eisai sign a License Agreement to Develop and
Commercialize Glufast, A Rapid-acting Insulin Secretagogue in 10
Asian Countries |
| June 12 |
China Biopharma Signed LOI to Acquire All the Interest of a Chinese
Regional Pharmaceutical Distribution Company |
| June 12 |
Artes Medical Forms New Subsidiary to Commercially Develop and
License Medical Applications of Its Microsphere Technology |
| June 12 |
Repligen Reports Ruling on Sanctions Motion Against ImClone |
| June 13 |
Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline |
| June 13 |
New Survey Shows Product Liability Litigation May Jeopardize
Treatment Outcomes for People with Severe Mental Illnesses |
| June 13 |
American Oriental Bioengineering Enters Into a Letter-of-Intent to
Acquire Established Plant Based Pharmaceutical Company |
| June 13 |
Reps. Hinchey & Stupak: FDA's Bond With Drug Industry Is As
Strong As Ever |
| June 13 |
Accentia Biopharmaceuticals' Majority-Owned Subsidiary, Biovest,
Receives Request From the Independent Data Monitoring Committee to
Conduct Interim Analysis of Anti-Cancer Vaccine, BiovaxID |
| June 13 |
Health Care Plans and Consumer Groups Unite and Call on Legislature
to Pass Rx Gift Disclosure Law |
| June 14 |
Interpublic Announces Development in SEC Investigation |
| June 14 |
Charles River Laboratories Completes Chinese Joint Venture |
| June 14 |
Canadian Levofloxacin Patent Upheld by Federal Appeal Court |
| June 14 |
Cordis Corporation Resolves Corporate Warning Letter |
| June 18 |
NicOx Provides an Update on NCX 4016 |
| June 18 |
Geron Increases Stake in TA Therapeutics Joint Venture |
| June 18 |
FDA Converts Telcyta Full Clinical Hold to Partial Hold |
| June 18 |
GlaxoSmithKline Expects to Launch Up to Five Major New Medicines
for Oncology in Next Three Years |
| June 18 |
Lexicon Pharmaceuticals Announces Two Agreements to Finance
Long-Term Drug Development Strategy |
| June 18 |
Nabi Biopharmaceuticals Announces Creation of Biologics Business
Unit & Provides Strategic Updates |
| June 18 |
Merck & Co. Ordered to Pay Attorneys' Fees, Costs Following
Vioxx Consumer Fraud Finding |
| June 18 |
The Public is Doubtful that Strengthening the FDA's Oversight of
the Prescription Drug Industry Will Make a Difference |
| June 19 |
Roche Acquires NimbleGen to Gain Entry Into High-Growth Research
Microarrray Market |
| June 19 |
Bayer Raises Guidance for 2007 and 2009 |
| June 19 |
Verispan Reports: Biotech Companies Cut Sales Forces, but Managed
Care Execs Want More Contact |
| June 19 |
Diamyd Continues Invalidated Study |
| June 19 |
Regulatory Cooperation Expanded |
| June 19 |
ZymoGenetics Establishes Global Collaboration With Bayer HealthCare
for Development and Commercialization of Recombinant Human Thrombin |
| June 19 |
Safety Measures for Oseltamivir Phosphate and Chugai's Future
Approach |
| June 19 |
Impax Announces Lawsuit Related to Generic Version of Depakote ER |
| June 19 |
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by
Bayer Schering Pharma for Early Detection of Alzheimer's Disease |
| June 19 |
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix
Patent Litigation |
| June 19 |
Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials |
| June 19 |
CuraGen to Close Pilot Manufacturing Plant |
| June 20 |
Shire In-Licenses Juvista (Human TGFbeta3) From Renovo |
| June 20 |
Heygood, Orr, Reyes & Bartolomei: $5.5 Million Award in First
Federal Fentanyl Patch Trial |
| June 20 |
New Potential Treatment in Development for Patients Facing Heart
Health Challenges |
| June 20 |
Proteros biostructures Announce Successful Achievement of Milestone
in Fragment-Based Protein Crystallography Collaboration |
| June 20 |
Texas Family Sues GlaxoSmithKline (GSK) Over Man's Heart Attack
Death Following Avandia Use |
| June 20 |
Pfizer Discontinues Clinical Trials for PF-3512676 Combined with
Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer |
| June 20 |
Coley Pharmaceutical Group Announces Pfizer's Discontinuation of
Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy
in Advanced Non Small Cell Lung Cancer |
| June 20 |
Wyeth Responds to Verdict in Diet Drug Case |
| June 21 |
Cardinal Health Completes Initial Tender Offer for VIASYS
Healthcare |
| June 21 |
WHI Study of Younger Postmenopausal Women Links Estrogen Therapy to
Less Plaque in Arteries |
| June 21 |
PharmalLive Releases from Pipeline to Market 2007, an Exclusive
Annual Special Report |
| June 22 |
Icagen Receives Notification from McNeil of Termination of
Collaboration Agreement |
| June 22 |
Viragen Streamlines Research Focus and Halts Further Development of
OVA System |
| June 22 |
Paion Reduces Number of Employees |
| June 22 |
Barr Receives Approval for Generic Vesanoid Capsules, 10 mg |
| June 22 |
European Medicines Agency Agrees on Action Plan Following the
Recall of Viracept and Recommends Suspension of the Marketing
Authorisation |
| June 22 |
Pharma Bloggers Discuss Delay in Maraviroc Approval, Removal of
Provisions in Prescription Drug User Fee Act, Triumph for Plavix
Marketers, and More on Sicko |
| June 25 |
AstraZeneca Announces Symbicort Is Now Available In The U.S. |
| June 25 |
European Medicines Agency Recommends Restricted Use for Piroxicam |
| June 25 |
Biodel Inc. Announces VIAject(TM) Data at Oral Presentation at the
American Diabetes Association Meeting |
| June 25 |
Apidra Improved A1C In People With Type 2 Diabetes When Added to
Basal Insulin and Oral Antidiabetic Treatments (BOT) |
| June 25 |
Roche and Toyama Chemical Enter Licensing Agreement to Develop
Potential Breakthrough Drug to Treat Rheumatoid Arthritis |
| June 25 |
New Data Show Patients Treated With Avandia (Rosiglitazone Maleate)
Incurred Lower Medical Costs and Used Fewer Healthcare Resources
When Compared to Patients Treated With Sulphonylureas |
| June 25 |
Generex Biotechnology to Initiate Phase III Clinical Trial of
Generex Oral-lyn in 2007 Third Quarter |
| June 25 |
Diabetes Patients Make Significant Gains in Disease Control; Still,
Nearly Half Fail to Reach ADA Treatment Goals |
| June 25 |
Coalition Urges American Medical Association to Halt Sale of
Physician Data to Pharmaceutical Marketing Firms |
| June 25 |
New Findings Show Half of Americans Surveyed Importing Drugs
without a Prescription |
| June 25 |
U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust
Lawsuits |
| June 26 |
Ventana Advises Shareholders to Defer Taking Any Action in Response
to Roche Offer |
| June 26 |
UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II
Development for Multiple Sclerosis |
| June 26 |
Encysive Pharmaceuticals Appoints New Chief Executive and Announces
Restructuring of Company Operations |
| June 26 |
Pharma ChemOutsourcing Conference Posts Attendee List for September
Custom Synthesis Blockbuster Show in New Jersey |
| June 26 |
Commonly Prescribed Antidepressants Associated with Lower Bone
Density in Older Men and Women |
| June 26 |
NextBio Announces License Agreement with Genzyme |
| June 26 |
Wyeth Licenses Drug Targets from Osteoporosis Collaboration with
Galapagos |
| June 26 |
Abbott and Genentech Announce Global, Integrated Research,
Development and Commercialization Collaboration in Oncology |
| June 26 |
Daiichi Sankyo Commences Patent Litigation Against Mylan in the
United States |
| June 26 |
Organon Announces Acquisition of Kadmus Pharmaceuticals' FAAH
Inhibitor Technology |
| June 26 |
Pharsight Invited to Present on Oncology Modeling and Simulation at
AAPS National Biotechnology Conference on June 28, 2007 |
| June 26 |
Biotechnology Council of New Jersey and Pennsylvania Bio to Host
Seventh Annual Biosciences Symposium |
| June 26 |
Amgen Submits Testimony to House Ways & Means Committee |
| June 26 |
First Consulting Group Acquires Zorch, Inc. |
| June 26 |
Clinquest Takes Stake in Enceladus |
| June 26 |
Physicians Favor a DTC Moratorium More Strongly Than Consumers,
though Both Groups Cite Public Safety as the Key Benefit, according
to New TNS Healthcare Research |
| June 27 |
inVentiv Health to Acquire AWAC, Leader in Providing Medical Cost
Containment Services to Payors |
| June 27 |
inVentiv Health to Acquire Chandler Chicco Agency |
| June 27 |
Vermont Attorney General Sorrell Releases Pharmaceutical Company
Report |
| June 27 |
Cardinal Health Reaffirms Fiscal 2008 Outlook; Raises Long-Term
Profit Goals |
| June 27 |
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot
Related Indications |
| June 27 |
Vasogen Reports on Outcome of FDA Meeting |
| June 27 |
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis
C Virus Infection |
| June 27 |
Biogen Idec Announces Preliminary Results of Its Modified ''Dutch
Auction'' Tender Offer |
| June 27 |
Roche Commences Tender Offer for Ventana for $75 Per Share in Cash |
| June 27 |
Update on Migenix Agreement with Schering-Plough for Hepatitis C
Virus Treatment |
| June 27 |
VASTox Announces Significant Progress in Pharmaceutical Services
Business |
| June 27 |
Guideline and Med Ad News Host Panel to Discuss Issues Surrounding
Patient Compliance |
| June 27 |
MichBio Announces Its 2007 Expo; Bio CEO to be Keynote Speaker |
| June 27 |
Spherix Signs Definitive Agreement for Sale of Information
Subsidiary |
| June 28 |
Pharsight Preferred Stockholders Elect to Convert Preferred Shares
Into Common Stock |
| June 28 |
Materia Licenses Metathesis Catalyst Platform to Eisai |
| June 28 |
Pfizer Board of Directors to Initiate Face-to-Face Meetings with
Company's Institutional Investors on Corporate Governance Policies
and Practices |
| June 28 |
Isotechnika Will Be Represented at the Canadian Dermatology Annual
Conference |
| June 28 |
Bespak plc Exubera Update |
| June 28 |
The General Public Supports Breaking Drug Patents To Ensure Access
To HIV/AIDS Drugs In Poorer Countries |
| June 28 |
Lawmakers Praise Committee Passage of Biologics Legislation |
| June 28 |
Bioscience Leaders Discuss Strategies to Propel Industry,
Innovations Throughout Southern California |
| June 28 |
Cardinal Health Completes Subsequent Tender Offer for VIASYS
Healthcare |
| June 28 |
Thallion Announces Sale of Majority Stake in Caprion Proteomics to
Great Point Partners |
| June 29 |
Genmab Regains Rights to HuMax-CD4 |
| June 29 |
Lorus Therapeutics Announces Receipt of Court Approval for Proposed
Plan of Arrangement |
| June 29 |
Prescription Access Litigation: Federal Judge Allows Zyprexa Class
Action to Go Forward |
| June 29 |
Urigen N.A., Inc. Completes Shareholder Meeting |
| June 29 |
Karo Bio Announces Delay in KB5359 Development |
| June 29 |
Yet Another Pfizer Whistleblower Comes Forth Through Blogs, CME
Criticism Continues, and Dr. Rost Gains Access to Astrazeneca
Ethics Violation Website |
| June 29 |
The International Society for Medical Publication Professionals
(ISMPP) Publishes Position Paper on the Role of the Professional
Medical Writer |
| June 29 |
Combination of Sartorius Biotech Division and Stedim Completed |
| June 29 |
Merck Names Peter Kellogg as Executive Vice President and Chief
Financial Officer |
| June 29 |
RAPS Holds Japan Seminar, High-Ranking Officials Participate |
